Treatability of HCV from heart transplants may broaden donor pool

The donor pool for heart transplants can potentially be expanded now that the infection from donor-derived hepatitis C is curable and well tolerated, according to a study published in JAMA Cardiology. The survival rates at 1 year were also similar in patients with and without donor-derived HCV, according to the study.

Read the full article here

Related Articles